| 产品描述: | 细胞可渗透的caspase-3抑制剂;Cell permeable caspase-3 inhibitor;; |
| 体内研究: |
早期 Z-DEVD-FMK (160 ng) 治疗可改善小鼠严重受控皮质撞击 (CCI) 引起的中枢神经系统创伤后的运动和认知功能。与使用 DMSO 载体治疗的创伤动物相比,使用 Z-DEVD-FMK (160 ng) 治疗可显著改善神经系统结果。 |
| 参考文献: |
1. Kanthasamy AG, et al. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. Free Radic Biol Med. 2006 Nov 15;41(10):1578-89. 2. Knoblach SM, et al. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab. 2004 Oct;24(10):1119-32. 3. Yakovlev AG, et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci. 1997, 17(19), 7415-7424. 4. Huang MY, et al. Chemotherapeutic agent CPT-11 eliminates peritoneal resident macrophages by inducing apoptosis. Apoptosis. 2016 Feb;21(2):130-42. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.496 ml |
7.478 ml |
14.955 ml |
| 5 mM |
0.299 ml |
1.496 ml |
2.991 ml |
| 10 mM |
0.15 ml |
0.748 ml |
1.496 ml |
| 50 mM |
0.03 ml |
0.15 ml |
0.299 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |